2C-T-32
A synthetic psychedelic compound
2C-T-32 is a synthetic psychedelic compound belonging to the 2C family of phenethylamines. It is known for its psychoactive effects, which are similar to those of other compounds in the 2C series, such as 2C-B and 2C-I.
Chemical Structure and Properties[edit | edit source]
2C-T-32 is chemically classified as a phenethylamine, with the full IUPAC name being 2-[4-(Ethylthio)-2,5-dimethoxyphenyl]ethanamine. The compound features a phenyl ring with two methoxy groups at the 2 and 5 positions, and an ethylthio group at the 4 position. This structural configuration is responsible for its unique pharmacological properties.
Pharmacology[edit | edit source]
The pharmacological profile of 2C-T-32 is not well-documented in scientific literature, as it is a relatively obscure compound. However, it is believed to act as a partial agonist at the 5-HT2A receptor, similar to other psychedelics in the 2C series. This receptor interaction is thought to be responsible for its hallucinogenic effects.
Effects[edit | edit source]
The effects of 2C-T-32 are largely anecdotal, as there is limited clinical research available. Users have reported experiencing altered states of consciousness, visual hallucinations, and changes in perception. The onset of effects typically occurs within 30 to 60 minutes after oral ingestion, with the experience lasting several hours.
Safety and Toxicity[edit | edit source]
Due to the lack of scientific studies, the safety profile of 2C-T-32 is not well understood. As with other research chemicals, there is a potential risk of adverse effects, including psychological distress and physiological harm. Users are advised to exercise caution and conduct thorough research before considering use.
Legal Status[edit | edit source]
2C-T-32 is not specifically scheduled under international drug control treaties. However, its legal status may vary by country, and it could be considered an analogue of other controlled substances, subject to local analogue laws.
History and Synthesis[edit | edit source]
2C-T-32 was first synthesized by the chemist Alexander Shulgin, who documented it in his book PiHKAL (Phenethylamines I Have Known And Loved). The synthesis involves the reaction of 2,5-dimethoxy-4-ethylthiophenethylamine with appropriate reagents to form the final compound.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
